All Stories

  1. A Novel Combinatorial Regimen Using Sorafenib and Uttroside B, A US FDA-designated ‘Orphan Drug’, for the Treatment of Hepatocellular Carcinoma
  2. Targeting acid ceramidase enhances antitumor immune response in colorectal cancer
  3. Modulatory Role of Phytochemicals/Natural Products in Cancer Immunotherapy
  4. Beyond cyclopamine: Targeting Hedgehog signaling for cancer intervention
  5. Data from DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer
  6. Data from DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer
  7. Supplementary Data from DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer
  8. Supplementary Data from DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer
  9. Supplementary Figure from DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer
  10. Supplementary Figure from DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer
  11. Supplementary Figure from DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer
  12. Supplementary Figure from DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer
  13. Supplementary Figure from DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer
  14. Supplementary Figure from DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer
  15. Supplementary Figure from DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer
  16. Supplementary Figure from DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer
  17. Augmented Efficacy of Uttroside B over Sorafenib in a Murine Model of Human Hepatocellular Carcinoma
  18. Development and Functional Characterization of a Versatile Radio-/Immunotheranostic Tool for Prostate Cancer Management
  19. DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer
  20. Augmented efficacy of uttroside B over sorafenib in a murine model of human hepatocellular carcinoma
  21. p27 as a Transcriptional Regulator: New Roles in Development and Cancer
  22. Regulatory role of SphK1 in TLR7/9‐dependent type I interferon response and autoimmunity
  23. TAMing pancreatic cancer: combat with a double edged sword
  24. Examination of the role of sphingosine kinase 2 in a murine model of systemic lupus erythematosus
  25. Corrigendum: Sphingosine 1-Phosphate: A Novel Target for Lung Disorders
  26. Targeting oncogenic transcription factors by polyphenols: A novel approach for cancer therapy
  27. Enhanced expression of histone chaperone APLF associate with breast cancer
  28. The Origin and Functions of Exosomes in Cancer
  29. Targeting S1PR1/STAT3 loop abrogates desmoplasia and chemosensitizes pancreatic cancer to gemcitabine
  30. Cardamonin inhibits colonic neoplasia through modulation of MicroRNA expression
  31. Sphingosine 1-Phosphate: A Novel Target for Lung Disorders
  32. Complementary and Alternative Medicines in Prostate Cancer
  33. The sphingosine-1-phosphate/sphingosine-1-phosphate receptor 2 axis regulates early airway T-cell infiltration in murine mast cell–dependent acute allergic responses
  34. K63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5
  35. A specific sphingosine kinase 1 inhibitor attenuates airway hyperresponsiveness and inflammation in a mast cell–dependent murine model of allergic asthma
  36. Sphingosine-1-Phosphate Links Persistent STAT3 Activation, Chronic Intestinal Inflammation, and Development of Colitis-Associated Cancer
  37. Innate immune agonist, dsRNA, induces apoptosis in ovarian cancer cells and enhances the potency of cytotoxic chemotherapeutics
  38. Sphingosine-1-phosphate signaling and its role in disease
  39. Extracellular and intracellular sphingosine-1-phosphate in cancer
  40. Phyllanthus Species
  41. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2
  42. A Novel Small-Molecule Inhibitor of Protein Kinase D Blocks Pancreatic Cancer Growth In vitro and In vivo
  43. Sesamin Manifests Chemopreventive Effects through the Suppression of NF-κB–Regulated Cell Survival, Proliferation, Invasion, and Angiogenic Gene Products
  44. Erratum
  45. Estradiol Induces Export of Sphingosine 1-Phosphate from Breast Cancer Cells via ABCC1 and ABCG2
  46. Escin, a Pentacyclic Triterpene, Chemosensitizes Human Tumor Cells through Inhibition of Nuclear Factor-κB Signaling Pathway
  47. Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabinein vitroand in orthotopic mouse model of human pancreatic cancer
  48. Inhibition of IkB kinase and NF-κB by a novel synthetic compound SK 2009
  49. Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate
  50. Inhibition of Viral Carcinogenesis by Phyllanthus amarus
  51. Molecular Targets of Nutraceuticals Derived from Dietary Spices: Potential Role in Suppression of Inflammation and Tumorigenesis
  52. Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer
  53. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX‐2, MMP‐9, VEGF and CXCR4 expression in an orthotopic mouse model
  54. Phyllanthus amarus Inhibits Cell Growth and Induces Apoptosis in Dalton's Lymphoma Ascites Cells Through Activation of Caspase-3 and Downregulation of Bcl-2
  55. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases
  56. Resveratrol addiction: To die or not to die
  57. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature
  58. Modification of Cysteine Residue in p65 Subunit of Nuclear Factor-κB (NF-κB) by Picroliv Suppresses NF-κB–Regulated Gene Products and Potentiates Apoptosis
  59. Modification of the cysteine residues in I B  kinase and NF- B (p65) by xanthohumol leads to suppression of NF- B-regulated gene products and potentiation of apoptosis in leukemia cells
  60. Neutrophil Gelatinase-Associated Lipocalin: A Novel Suppressor of Invasion and Angiogenesis in Pancreatic Cancer
  61. Cancer is a Preventable Disease that Requires Major Lifestyle Changes
  62. Cancer is a Preventable Disease that Requires Major Lifestyle Changes
  63. Potential of Spice-Derived Phytochemicals for Cancer Prevention
  64. Resveratrol: A multitargeted agent for age-associated chronic diseases
  65. Toxicity Profile of Lutein and Lutein Ester Isolated From Marigold Flowers (Tagetes erecta)
  66. An Extract of Phyllanthus amarus Protects Mouse Chromosomes and Intestine from Radiation Induced Damages
  67. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's Lymphoma Ascites tumor in mice
  68. Inhibition of Drug Metabolizing Enzymes (Cytochrome P450) in Vitro as Well as in Vivo by Phyllanthus amarus SCHUM & THONN
  69. Chemoprotective activity of an extract of Phyllanthus amarus against cyclophosphamide induced toxicity in mice
  70. A Preliminary Assessment of the Acute and Subchronic Toxicity Profile of Phase2: An α-Amylase Inhibitor
  71. Modulation of Haematopoetic System and Antioxidant Enzymes by Emblica Officinalis Gaertn and its Protective Role Against γ-radiation Induced Damages in Mice
  72. Protective Effect of an Extract of Phyllanthus amarus against Radiation-induced Damage in Mice